BACK
GLOBAL EXECUTIVE MOVES

February 2021
Dave Picard Joins Slayback Pharma as Chief Commercial Officer
Slayback Pharma LLC has named Dave Picard Chief Commercial Officer, leading commercial strategy and infrastructure. He joins from AmerisourceBergen, where he led as Senior Vice President of Global Generic Pharmaceuticals. Prior to that, he served Sandoz for 13 years, ultimately as Vice President of Institutional Sales and Marketing. Early on in his career, he spent time as Senior Manager of Institutional Marketing for Apothecon / Bristol-Myers Squibb.
Slayback is a New Jersey-based company focused on complex generic and specialty pharmaceutical products with a team of 85 employees and operations in the U.S., India and Europe.